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Abstract 
Background: Agammaglobulinemia (AGM) is a genetic immune system dis-
order in which the body could not produce antibodies. There are two types of 
this disease: X-linked AGM (XLA) and autosomal forms. X-linked agammag-
lobulinemia results from a mutation in the gene for Bruton’s tyrosine kinase 
(BTK), found on the X chromosome. Mutations in BTK result in lack of ma-
ture B-cells and immunoglobulins of all classes. There are 8 types of autosom-
al forms which are reflected in different defective genes. 7-year-old male pa-
tient at the age of 1 - 6, was encountered the recurrent broncho-pulmonary 
and gastro-intestinal infections, furunculosis and recurrent otitis. Also, be-
cause of the strain, pain and swelling on the 4th finger of the right hand it was 
suspected that the patient had rheumatoid arthritis. On immunological inves-
tigation, we have found out of absent of B lymphocyte. Level of IgG was 10 
times less; IgA, IgM and IgE levels were 3 to 8 times less than the norm. Quan-
tity of T-lymphocytes: absolute number of CD4+ lymphocytes increased, CD3+ 
and CD8+ lymphocytes were also high. Phagocyte activity in NBT, absolute 
number of NK cells and IRI index were 2 times lower than the norm. Genetical-
ly analysis has discovered the presence of abnormal homozygous BLNK gene. 
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1. Introduction 
Agammaglobulinemia is a disorder which passed through families when a per-
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son has very low levels of protective immune system proteins—immunoglobulins 
(Ig). Low levels of these antibodies make you more likely to get infected [1] [2] 
[3]. Mother carrying the defective gene passes this anomaly to the fetus; moreo-
ver, the clinical signs of disease are usually observed in boys. There are two types 
of this disease (Figure 1). 
X-linked agammaglobulinemia results from a mutation in the gene for Bru-
ton’s tyrosine kinase (BTK), found on the X chromosome. BTK is a nonreceptor 
cytoplasmic tyrosine kinase involved in B-cell receptor intracellular signaling, 
developing and differentiating [4] [5]. Loss-of-function mutations in BTK result 
in lack of mature B-cells and immunoglobulins of all classes. 50% of the muta-
tions are new and these patients do not have a family history of the current con-
dition. The other type with low or absent serum immunoglobulins is early onset 
non-Bruton agammaglobulinemia. Agammaglobulinemias with autosomal re-
cessive/dominant heritage represent a very heterogeneous group, such as 
common immunoglobulin deficiency with increased only immunoglobulin M 
(hyper-IgM syndrome), which is also discussed separately. Approximately 90% 
of patients with early-onset agammaglobulinemia and absence of B cells have 
abnormalities in the Btk gene [3] [6] [7].  
Similar phenotype to that of the X-linked form, autosomal inheritance of 
agammaglobulinemia, has been detected in a small number of families and ac-
counts for up to 15% of patients with agammaglobulinemia. Males and females 
are usually affected in equal order. More than 100 cases of autosomal agammag-
lobulinemia have then been informed to date. Their diagnosis was suspected on 
the basis of early susceptibility to severe recurrent or persistent infections [8]. 
The case is particularly true if the parents are consanguineous or the ones be-
longing to an isolated population. Abnormal laboratory parameters include low 
Ig levels and low or absent peripheral blood mature B lymphocytes [5] [9]. For 
determine the genetic defect and to confirm the diagnosis, should be performed 
molecular genetic testing. Table 1 shows the existing 8 types of agammaglobuli-
nemia (AGM) which are reflected in defective genes. 
We have patient withAGM4 type of disease which caused by homozygous 
mutation in the BLNK gene on chromosome 10q23.2. In these case B-cell devel-
opment fails because of mutations B-cell linker protein [2] [8]. 
The BLNK gene encodes a B-cell linker protein. Linker or adaptor proteins 
can provide mechanisms by which receptors can increase and regulate to down-
stream effectors proteins. BLNK has essential role for normal B-cell develop-
ment. BLNK is exclusively expressed in hematopoietic cells, mainly in progeny- 
 
 
Figure 1. Two types of agammaglobulinemias. 
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Table 1. Types and defective genes of autosomal agammaglobulinemias. 
Disease Gene/Locus Location Inheritance 
AGM1 IGHM 14q AR 
AGM2 IGLL1 22q11 AR 
AGM3 CD79A 19q13.2 AR 
AGM4 BLNK 10q23.2 AR 
AGM5 LRRC8 9q34.11 AD 
AGM6 CD79B 17q23.3 AR 
AGM7 PIK3R1 5q13.1 AR 
AGM8 TCF3 19p13.3 AD 
AGM: agammaglobulinemia; AR: autosomal recessive; AD: autosomal dominant 
 
 
Figure 2. Different types of antibody deficiencies. 
 
tor if myeloid cells, also in B cells [2] [9]. 
Clinical features on autosomal recessive agammaglobulinemia and X-linked 
agammaglobulinemia are similarly identical. When maternal transplacentally 
passed antibodies disappear patients develop recurrent pyogenic infections from 
6 months of age. Sinopulmonary infections (especially sinusitis, pneumonia), 
otitis media are most commonly, followed by skin infections, gastrointestinal 
infections, sepsis, meningitis and osteomyelitis [3] [8] [10] [11] [12]. 
2. Patients and Materials 
During 2010-2017 years Immunology Department and Pediatric Department of 
Azerbaijan Medical University have detected 35 patients with Antibody defi-
ciencies, out of which 22 patients with CVID, 6 patients with sIgA deficiency, 4 
patients with Bruton disease, 1 patient with AGM4 and 2 patient with HIGM. 
This investigation had been done in frame of collaboration with biological la-
boratory of Khazar University research group. Different types of antibody defi-
ciencies are depicted in Figure 2. 
3. Case Report 
7-year-old male patient was born with normal height and weight from the first 
pregnancy. Parents were close relatives (cousins). Physical and mental develop-
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ment of the patient proceeded normally until 1 year. Nevertheless, later, at the 
age of 1 - 6, he started to face the recurrent broncho-pulmonary and ga-
stro-intestinal infections, furunculosis and recurrent otitis. At the age of 6 pa-
tient had pneumonia with high fever and respiratory symptoms. Also, because of 
the strain, pain and swelling on the 4th finger of the right hand it was suspected 
that the patient had rheumatoid arthritis (Figure 3).  
4. Discussion 
Interestingly, there was not observed any pathological change in the mile-wrist 
joint in radiography. ASO, RF indexes were negative and CRP was high (110 
mg/l). We have detected hepatosplenomegaly on US investigation (hepatomegaly: 
left part-57mm, splenomegaly: 96 mm). ANA, specific M. tuberculosis and bru-
cellosis antibodies were also negative. On X-Ray investigation it was detected 
pneumonia of left the part of lung and hidrotoraks. 
4.1. Immunology 
On immunological investigation, we have found out that the type of B lympho-
cyte was absent. Level of IgG was 10 times less; IgA, IgM and IgE levels were 3 to 
8 times less than the norm. There were some noticeable changes in the peripher-
al blood indexes: leukocytosis, lymphopenia and monocytosis; quantity of T- 
lymphocytes: absolute number of CD4+ lymphocytes increased, CD3+ and 
CD8+ lymphocytes were also high. Phagocyte activity in NBT, absolute number 
of NK cells and IRI index were 2 times lower than the norm. Some these findings 
are depicted on Table 2. 
 
 
Figure 3. Clinical fetures of Rheumatoid Arthritis in patient with AGM4. 
 
Table 2. Periodically immunological results of AGM4 patient. 
 Before İVİG After IVIG Norm 
Leukocyte 109/l 20.6 14.2 4.0 - 7.3 
Lymphocyte % 26 29 36 - 43 
İgA (q/l) 0 0.1 0.83 - 2.17 
İgM (q/l) 0 0.3 0.55 - 2.10 
İgG (q/l) total 0.6 5.0 6.5 - 14.1 
İgE (ME/ml) 0 0.8 0 - 60 
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4.2. Molecular Genetics 
HOMOZYGOUS VARIANTS 
BLNK: OMIM AR for Agammaglobulinemia 4 (absent pre-B, mature B cells, 
but normal numbers of pro-B cells; recurrent otitis, pneumonia). BLNK is essen-
tial for normal B-cell development.  
HETEROZYGOUS VARIANTS (only inherited AD or possible compound 
heterozygous) 
CFI: CFI deficiency can cause hemolytic uremic syndrome with clinical im-
pact, such as hemolytic anemia, proteinuria, decreased renal function and 
hypertension. 
PSTPIP1: OMIM AD: Pyogenic sterile arthritis, pyoderma gangrenosum, and 
acne syndrome. 
C5: OMIM AD and AR for complement component 5 deficiency (seborrheic 
dermatitis, intractable diarrhea, recurrent local and systemic infections) (Table 
3). 
Genetically analysis has discovered the presence of abnormal homozygous 
BLNK, heterozygous CFI, PSTPIP1 and C5 genes. 
4.3. Treatment 
Antibacterial treatment during 2 weeks, non-steroid and steroid medicines, oth-
er symptomatic treatment. Replacement therapy by IVIG-Octagam was given in 
dose 400 - 600 mg/kg, every 4 weeks, but it was not regularly received. 
 
Table 3. Genetic results of our patient M. D., 7 years old. 
HOM         
GENE CHR POS SNP ID IMPACT AA ID MAF READS CADD score 
BLNK 10 97964346 rs184808145 STOP_GAINED R282* ENST00000224337 <0.01 684 38 
HET         
GENE CHR POS SNP ID IMPACT AA ID MAF READS CADD score 
IL12B 5 158749490 rs139186048 MISSENSE E132K ENST00000231228 <0.01 426 26.3 
DOCK8 9 418066 . SPLICE_SITE_ACCEPTOR NA ENST00000453981 NA 155 18.77 
CFI 4 110682814 . MISSENSE D173N ENST00000394635 <0.01 645 0.001 
PSTPIP1 15 77310863 rs201872851 MISSENSE T68M ENST00000558012 <0.01 450 25 
VPS13B 8 100844858 rs149842139 MISSENSE R3223W ENST00000358544 <0.01 559 25.4 
NCF4 22 37267701 rs150103256 MISSENSE V160M ENST00000397147 <0.01 204 4.579 
DNAAF1 16 84208329 rs139519641 SPLICE_SITE_DONOR NA ENST00000378553 <0.01 528 11.68 
C5 9 123785738 rs34552775 MISSENSE L354M ENST00000223642 <0.01 404 25 
NCF1 7 74197326 . MISSENSE N166D ENST00000289473 <0.01 673 0.003 
GENE: gene name; MPACT: consequence of variant (e.g. missense, stop gain, splice-site); CHR: chromosome; POS: chromosomal position (bases); ID: 
Transcript ID; SNP ID: rs number; R: base in reference genome; MAF: minor allele frequency; A: alternative base in sample; NA: not annotated; AA: 
change on amino acid level; READS: number of sequencing reads covering the variant. 
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5. Outcomes 
The patient is under our control for 2 years. In this period the number of diseases, 
especially pneumonia, decreased against the background of immunological treat-
ment. Pain in the joints falls and can open the finger. The patient’s parents were 
informed of the illness, and a prenatal diagnosis was recommended during the 
next pregnancy. 
6. Conclusion 
Thus, based on the detection of a serious deficiency of humoral immunity and 
BLNK gene mutation, patient has rarely diagnosed disease—agammaglo-bulinemia 
type 4 (AGM4). 
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